Combined use of plasma p‐tau 181 and neurofilament light chain in Subjective Cognitive Decline and M...
Combined use of plasma p‐tau 181 and neurofilament light chain in Subjective Cognitive Decline and Mild Cognitive Impairment: future perspective and clinical applicability
About this item
Full title
Author / Creator
Publisher
Hoboken: John Wiley and Sons Inc
Journal title
Language
English
Formats
Publication information
Publisher
Hoboken: John Wiley and Sons Inc
Subjects
More information
Scope and Contents
Contents
Background
There is an urgent need to move the use of plasma biomarkers from research setting to clinical practice for the early detection of Alzheimer’s disease (AD). The aims of the study were to explore the combined use of plasma p‐tau181 and NfL in Subjective Cognitive Decline (SCD) and Mild Cognitive Impairment (MCI) patients, evaluating di...
Alternative Titles
Full title
Combined use of plasma p‐tau 181 and neurofilament light chain in Subjective Cognitive Decline and Mild Cognitive Impairment: future perspective and clinical applicability
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11716128
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11716128
Other Identifiers
ISSN
1552-5260
E-ISSN
1552-5279
DOI
10.1002/alz.085914
